Health and Wellness
WHO backs dolutegravir, injectables in new HIV care guidance
WHO has updated its HIV guidelines, reaffirming dolutegravir, backing long-acting injectables, revising protease inhibitor choices and TB prevention, aiming to improve outcomes and advance efforts to end AIDS.